Triple-negative breast cancers (TNBCs) that lack expression of estrogen receptor-alpha (ER-α), progesterone receptor (PR) and human epidermal growth factor receptor-2 (HER-2), is more prevalent among women of African descent and Latino women patients [4]. This evidence concerns the gene PGR and triple-negative breast carcinoma.